title: [Nifurtimox, a bright future for treatment of Chagas disease].
abstract: Nifurtimox is one of the two molecules used for treatment of Chagas disease. Although posology has not yet been clearly defined, nifurtimox is increasingly used, especially in combination with eflonithin. Nifurtimox is perfectly suited to the WHO's Chagas disease eradication program.
authors.affiliation: Service de Pharmacie Hspitalière. Hôpital d'lnstruction des Armées Laveran, Marseille.
authors.forename: A
authors.initials: A
authors.lastname: Wolf
authors.forename: C
authors.initials: C
authors.lastname: Boulliat
authors.forename: C
authors.initials: C
authors.lastname: Coillot
authors.forename: M
authors.initials: M
authors.lastname: Rouault
authors.forename: K
authors.initials: K
authors.lastname: Gaillard
authors.forename: C
authors.initials: C
authors.lastname: Beranger
authors.forename: M
authors.initials: M
authors.lastname: Oliver
mesh_terms: D002598:Chagas Cardiomyopathy / Q000517:prevention & control; D014355:Chagas Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use; D006801:Humans; D009547:Nifurtimox / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000302:isolation & purification
chemical_list: D014344:Trypanocidal Agents; D009547:Nifurtimox; D000518:Eflornithine